ALZHEIMER’S DISEASE PEPTIDES FOR YOUR RESEARCH

 

Alzheimer’s disease is one of the most complex and complicated diseases researchers have ever studied. US National Institutes of Health reports over 1,500 current or completed clinical trials to evaluate various treatments in Alzheimer`s disease. 

The diverse array of possible aggregation states makes working with Amyloid β-Peptides very challenging but extremely promising at the same time.